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World Hepatitis Day 2013: Know it, Confront it
Viral hepatitis has not received the level of attention 
that it warrants. However, the global picture began to 
change in May, 2010, when the World Health Assembly 
adopted its ﬁ rst resolution on viral hepatitis.1
Recent data clearly show the magnitude of the 
challenge. Hepatitis A and E together caused more 
than 34 million cases of illness in 2005.2 According to 
Global Burden of Disease3 estimates, 1·3 million deaths 
occurred in 2010 from diseases related to hepatitis B 
and C. To put this ﬁ nding into context, malaria and HIV 
caused about 1·2 million and 1·5 million deaths in 2010, 
respectively.3 Much of the suﬀ ering caused by hepatitis 
is unnecessary. Safe and eﬀ ective vaccines for hepatitis A 
and B are available. Hepatitis C is curable, and hepatitis 
B treatable. Improvements in sanitation, hygiene, and 
blood and injection safety can reduce the spread of viral 
hepatitis and many other diseases.
In 2012 WHO, in collaboration with the World 
Hepatitis Alliance, did the ﬁ rst worldwide survey to 
investigate how governments are addressing viral 
hepatitis.4 The ﬁ ndings will be released on July 28, 
2013—World Hepatitis Day.1 126 of WHO´s 194 member 
states submitted answers to the survey—a response rate 
of 64·9%. Slightly more than a third of the countries 
reported the existence of a national hepatitis strategy 
or plan. Less than half of respondents reported holding 
events for World Hepatitis Day 2012, and less than a 
third had funded any other type of hepatitis public 
awareness campaign in recent months. The survey also 
asked questions about surveillance, disease prevention 
measures, and policies and practices for screening, care, 
and treatment.4 
The ﬁ ndings provide a crucial baseline against which 
progress can be measured in coming years. We hope 
that the report will also stimulate dialogue with respect 
to the roles of all stakeholders in forging a cohesive and 
eﬀ ective response to viral hepatitis. For example, civil 
society organisations can help to strengthen and call 
attention to governmental responses to hepatitis, in line 
with their involvement in many other pressing health 
issues. The relatively high response rate for the survey is 
an aﬃ  rmation of the global community’s concern about 
viral hepatitis. 
However, low response rates from the WHO African 
Region and Western Paciﬁ c Region suggest that some 
of those member states do not see viral hepatitis as 
a priority disease. Further, the fact that so few survey 
respondents reported having a national strategy or 
plan for viral hepatitis is alarming. Such documents 
provide foundations for strong national leadership 
to address the complex array of issues to improve 
prevention, treatment, and care.
Another component of an eﬀ ective public health 
response is to raise awareness of hepatitis among the 
general public, policy makers, and health-care workers. 
Governments should commemorate World Hepatitis 
Day and promote other awareness-raising activities. 
The World Hepatitis Alliance has adopted the three 
wise monkeys motif (ﬁ gure) for World Hepatitis Day 
to call attention to the widespread public ignorance 
surrounding viral hepatitis, which will not end unless 
policy makers show better leadership on this issue. The 
World Hepatitis Day slogan is: “This is hepatitis...Know 
it. Confront it.” We invite readers to ask themselves why, 
given its burden, viral hepatitis is absent from major 
global health initiatives.
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Figure: The three wise monkeys call attention to how people block out the reality of viral hepatitis
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